These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1323530)

  • 1. Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.
    Bajaj MS; Kew RR; Webster RO; Hyers TM
    Inflammation; 1992 Jun; 16(3):241-50. PubMed ID: 1323530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of tumor necrosis factor-alpha-induced priming of fMet-Leu-Phe-stimulated neutrophils by pentoxifylline.
    Dunzendorfer S; Schratzberger P; Reinisch N; Kähler CM; Wiedermann CJ
    Immunol Lett; 1997 Jul; 58(2):75-8. PubMed ID: 9271316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumor necrosis factor on the generation of chlorinated oxidants by adherent human neutrophils.
    Test ST
    J Leukoc Biol; 1991 Aug; 50(2):131-9. PubMed ID: 1649239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.
    Berkow RL; Wang D; Larrick JW; Dodson RW; Howard TH
    J Immunol; 1987 Dec; 139(11):3783-91. PubMed ID: 2824615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
    Farmer JC; Burkey TH; Kew RR; Webster RO
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF.
    Kharazmi A; Nielsen H; Bendtzen K
    Immunobiology; 1988 Sep; 177(4-5):363-70. PubMed ID: 2848761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-Met-Leu-Phe.
    Spilberg I; Mehta J; Muniain MA; Simchowitz L; Atkinson J
    Inflammation; 1984 Mar; 8(1):73-86. PubMed ID: 6325345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors.
    Kitchen E; Condliffe AM; Rossi AG; Haslett C; Chilvers ER
    Br J Pharmacol; 1996 Mar; 117(5):979-85. PubMed ID: 8851521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burst.
    Khwaja A; Carver JE; Linch DC
    Blood; 1992 Feb; 79(3):745-53. PubMed ID: 1370644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol myristate acetate enhances human polymorphonuclear neutrophil release of granular enzymes but inhibits chemokinesis.
    Hoult JR; Nourshargh S
    Br J Pharmacol; 1985 Nov; 86(3):533-7. PubMed ID: 4063581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoattractant-induced release of elastase by tumor necrosis factor-primed human neutrophils: auto-regulation by endogenous adenosine.
    Ottonello L; Amelotti M; Barbera P; Dapino P; Mancini M; Tortolina G; Dallegri F
    Inflamm Res; 1999 Dec; 48(12):637-42. PubMed ID: 10669115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of the 47-kilodalton protein phosphorylation from degranulation and superoxide production in neutrophils.
    Sha'afi RI; Molski TF; Gomez-Cambronero J; Huang CK
    J Leukoc Biol; 1988 Jan; 43(1):18-27. PubMed ID: 2826626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulus interactions in release of superoxide anion (O2-) from human neutrophils. Further evidence for multiple pathways of activation.
    Bender JG; Van Epps DE
    Inflammation; 1985 Mar; 9(1):67-79. PubMed ID: 2984122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of superoxide anion and hydrogen peroxide by human neutrophilic granulocytes during chemotactic migration towards f-Met-Leu-Phe, C5a, leukotriene B4, monocyte-derived chemotaxin/IL-8 and platelet-activating factor.
    Kownatzki E; Uhrich S
    Int Arch Allergy Appl Immunol; 1990; 93(4):344-9. PubMed ID: 1966131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C2-ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils.
    Richard A; Bourgoin S; Naccache PH; L'Heureux GP; Krump E; McColl SR; Pelletier G
    Biochim Biophys Acta; 1996 Jan; 1299(2):259-66. PubMed ID: 8555272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of fMLP pocket dimensions and features using formyltetrapeptides.
    Cavicchioni G; Varani K; Niccoli S; Rizzuti O; Spisani S
    J Pept Res; 1999 Oct; 54(4):336-43. PubMed ID: 10532239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.